Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
208 hedge funds and large institutions have $1.18B invested in Immunogen Inc in 2018 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 27 closing their positions.
660% more call options, than puts
Call options by funds: $16.9M | Put options by funds: $2.22M
37% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 27
5% more funds holding
Funds holding: 198 → 208 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 61
3% less capital invested
Capital invested by funds: $1.22B → $1.18B (-$41.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$39.6M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$18.5M |
| 3 |
BlackRock
New York
|
+$10.1M |
| 4 |
BNP Paribas Asset Management
Paris,
France
|
+$9.02M |
| 5 |
Millennium Management
New York
|
+$5.57M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$22.5M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$16.9M |
| 3 |
O
OrbiMed
New York
|
-$13.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.6M |
| 5 |
ClearBridge Investments
New York
|
-$10.4M |
IMGN Hedge Fund Activity: Q3 2018 in Review
208 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2018, worth a combined $1.18B — down 3.4% from $1.22B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new IMGN positions and 27 closed out — a net gain of 10 holders — while 61 added to existing stakes and 61 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $39.6M. The largest seller was Capital Research Global Investors, cutting an estimated $22.5M.
- 208 institutional investors held Immunogen Inc (IMGN) as of Q3 2018, up from 198 in Q2 2018.
- Funds reported $1.18B of Immunogen Inc stock for Q3 2018, down 3.4% quarter-over-quarter.
- 37 funds opened new Immunogen Inc positions in Q3 2018 and 27 closed out, a net change of +10 holders.
- The largest Immunogen Inc buyer in Q3 2018 was Point72 Asset Management, an estimated $39.6M added.
- The largest Immunogen Inc seller in Q3 2018 was Capital Research Global Investors, an estimated $22.5M sold.
Based on aggregated 13F filings for Q3 2018.